Powerful new technologies have been driving forward immense and exciting changes in clinical practice.
The days of peering down the microscope to detect chromosome abnormalities are gone, replaced by chromosome analysis at the genomic level. Invasive Down syndrome tests in pregnancy have made way for the evaluation of fetal DNA in maternal blood. And instead of laborious gene-by-gene targeted sequencing, we can now sequence all of our genes in parallel in a single experiment.
The course has been approved for distance-learning continuing professional development (CPD) by the Royal College of Pathologists (RCPath): for 15 CPD credits.
Understand and apply molecular genetic techniques
This postgraduate-level course, in combination with Genomic Technologies in Clinical Diagnostics: Next Generation Sequencing Technologies, will help you understand these new and established genetic technologies, and their application to clinical practice.
This course focuses on molecular techniques. By the end, you will be able to demonstrate knowledge and applicability of the molecular principles behind:
- array comparative genomic hybridisation (array CGH);
- karyotyping;
- fluorescent in situ hybridisation (FISH);
- Southern blotting;
- multiplex ligation probe amplification (MLPA);
- polymerase chain reaction (PCR) and Sanger sequencing;
- quantitative fluorescent PCR (QF-PCR);
- single nucleotide polymorphism (SNP) genotyping and genome wide association studies (GWAS);
- and the extraction and analysis of cell free fetal DNA, including non-invasive prenatal testing (NIPT).
Through practice exercises each week, you will evaluate which laboratory investigations are most suitable for a given clinical scenario.
What topics will you cover?
- Polymerase chain reaction (PCR)
- Sanger sequencing
- Southern blotting
- Multiplex ligation probe amplification (MLPA)
- Array comparative genomic hybridisation (array CGH)
- Karyotyping
- Fluorescent in situ hybridisation (FISH)
- Quantitative fluorescent PCR (QF-PCR)
- Single nucleotide polymorphism (SNP) genotyping and genome wide association studies (GWAS)
- The extraction and analysis of cell free fetal DNA, including non-invasive prenatal testing (NIPT).